DEBORAH CHARVAT: Open Payments
NPI 1255651212 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 11 payments from 9 companies in 2025. Trend: 2023 $252 · 2024 $582 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| CSL Behring | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: MOUNJARO, Andembry, REPATHA, Ozempic, KRYSTEXXA, PREVNAR 20, BREZTRI, ZORYVE.
Industry payments across FL — which companies pay providers there.
